Overactive Bladder - Results from #2260

Association of overactive bladder and C-reactive protein levels. Results from the Boston Area Community Health (BACH) Survey - Abstract January 5, 2012

High classification of chronic heart failure increases risk of overactive bladder syndrome and lower urinary tract symptoms - Abstract January 4, 2012

Neuroprotection of green tea catechins on surgical menopause-induced overactive bladder in a rat model December 26, 2011

Sustained improvement in patient-reported outcomes during long-term fesoterodine treatment for overactive bladder symptoms: Pooled analysis of two open-label extension studies - Abstract December 23, 2011

Current management and future perspectives of overactive bladder (OAB) pharmacotherapy - Abstract December 22, 2011

Cost-effectiveness of percutaneous tibial nerve stimulation versus extended release tolterodine for overactive bladder - Abstract December 21, 2011

Behavioral versus drug treatment for overactive bladder in men: The Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial - Abstract December 20, 2011

Characteristics and impact of interrupted sleep in women with overactive bladder - Abstract December 12, 2011

Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder December 9, 2011

Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist - Abstract December 6, 2011

Co-administration of an α(1) -blocker improves the efficacy and safety of antimuscarinic agents in rats with detrusor overactivity - Abstract December 5, 2011

Blebbistain, a myosin II inhibitor, as a novel strategy to regulate detrusor contractility in a rat model of partial bladder outlet obstruction - Abstract December 5, 2011

Bladder outlet obstruction induced expression of prostaglandin E(2) receptor subtype EP4 in the rat bladder: A possible counteractive mechanism against detrusor overactivity - Abstract December 5, 2011

Prospective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxinA for refractory idiopathic detrusor overactivity - Abstract November 30, 2011

Korean version of the overactive bladder symptom score questionnaire: Translation and linguistic validation - Abstract November 29, 2011

The impact of overactive bladder on health-related quality of life, sexual life and psychological health in Korea - Abstract November 28, 2011

Commonly used antihypertensives and lower urinary tract symptoms: Results from the Boston Area Community Health (BACH) Survey - Abstract November 22, 2011

Anticholinergics for overactive bladder therapy: Central nervous system effects - Abstract November 21, 2011

Efficacy and tolerability of combined medication of two different antimuscarinics for treatment of adults with idiopathic overactive bladder in whom a single agent antimuscarinic therapy failed - Abstract November 18, 2011

Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) study - Abstract November 17, 2011

Page 114 of 122